» Articles » PMID: 33821540

New Paradigm in NKT Cell Antigens: MCS-0208 (2-(Hydroxymethyl)phenylthio-phytoceramide) - an Aryl-Phytoceramide Compound with a Single Hydroxyl Group Stimulates NKT Cells

Overview
Journal ChemMedChem
Specialties Chemistry
Pharmacology
Date 2021 Apr 6
PMID 33821540
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Natural Killer T (NKT) cells play an important role in the immune response and can be activated by glycolipids presented by CD1d protein. We present MCS-0208, an unprecedented arylthioether-phytoceramide able to induce potent invariant NKT (iNKT) cell activation, notably when tested in human iNKT cells. This arylsphingolipid analog has a simple phenyl group containing a single hydroxyl substituent as a surrogate of the sugar ring. The phenylthioether structure contrasts with α-galactosylceramide (1), the prototypical glycolipid used to induce iNKT cell stimulation, where the galactose 2'-OH and 3'-OH substituents are accepted as the minimal footprint and considered critical for NKT T cell receptor (TCR) recognition. A computational study supports the recognition of aromatic compound by the CD1d and TCR proteins as radically new structures for NKT cell stimulation.

Citing Articles

New Paradigm in NKT Cell Antigens: MCS-0208 (2-(Hydroxymethyl)phenylthio-phytoceramide) - an Aryl-Phytoceramide Compound with a Single Hydroxyl Group Stimulates NKT Cells.

Borras-Tuduri R, Alcaide A, Aspeslag S, Usero L, Serra C, Roura-Mir C ChemMedChem. 2021; 16(16):2491-2496.

PMID: 33821540 PMC: 8453509. DOI: 10.1002/cmdc.202000992.

References
1.
Harrak Y, Barra C, Delgado A, Castano A, Llebaria A . Galacto-configured aminocyclitol phytoceramides are potent in vivo invariant natural killer T cell stimulators. J Am Chem Soc. 2011; 133(31):12079-84. DOI: 10.1021/ja202610x. View

2.
Brennan P, Cheng T, Pellicci D, Watts G, Veerapen N, Young D . Structural determination of lipid antigens captured at the CD1d-T-cell receptor interface. Proc Natl Acad Sci U S A. 2017; 114(31):8348-8353. PMC: 5547638. DOI: 10.1073/pnas.1705882114. View

3.
Kerzerho J, Yu E, Barra C, Alari-Pahissa E, Alari-Pahisa E, Girardi E . Structural and functional characterization of a novel nonglycosidic type I NKT agonist with immunomodulatory properties. J Immunol. 2012; 188(5):2254-65. PMC: 3288653. DOI: 10.4049/jimmunol.1103049. View

4.
Kishi J, Inuki S, Kashiwabara E, Suzuki T, Dohmae N, Fujimoto Y . Design and Discovery of Covalent α-GalCer Derivatives as Potent CD1d Ligands. ACS Chem Biol. 2020; 15(2):353-359. DOI: 10.1021/acschembio.9b00700. View

5.
Fujio M, Wu D, Garcia-Navarro R, Ho D, Tsuji M, Wong C . Structure-based discovery of glycolipids for CD1d-mediated NKT cell activation: tuning the adjuvant versus immunosuppression activity. J Am Chem Soc. 2006; 128(28):9022-3. DOI: 10.1021/ja062740z. View